Prediction of organ-confined prostate cancer: incremental value of MR imaging and MR spectroscopic imaging to staging nomograms.
暂无分享,去创建一个
M. Kattan | H. Hricak | P. Scardino | K. Kuroiwa | Hui-Ni Chen | Liang Wang
[1] H. Hricak,et al. Endorectal MR imaging in the evaluation of seminal vesicle invasion: diagnostic accuracy and multivariate feature analysis. , 2006, Radiology.
[2] Lawrence H Schwartz,et al. Combined endorectal and phased-array MRI in the prediction of pelvic lymph node metastasis in prostate cancer. , 2006, AJR. American journal of roentgenology.
[3] M. Kattan,et al. Correlation of proton MR spectroscopic imaging with gleason score based on step-section pathologic analysis after radical prostatectomy. , 2005, Radiology.
[4] Vassilis Poulakis,et al. Preoperative neural network using combined magnetic resonance imaging variables, prostate specific antigen and Gleason score to predict prostate cancer stage. , 2004, The Journal of urology.
[5] P. Carroll,et al. Organ-confined prostate cancer: effect of prior transrectal biopsy on endorectal MRI and MR spectroscopic imaging. , 2004, AJR. American journal of roentgenology.
[6] Hedvig Hricak,et al. Pretreatment evaluation of prostate cancer: role of MR imaging and 1H MR spectroscopy. , 2004, Radiographics : a review publication of the Radiological Society of North America, Inc.
[7] Michael W Kattan,et al. Prostate cancer: detection of extracapsular extension by genitourinary and general body radiologists at MR imaging. , 2004, Radiology.
[8] Michael W Kattan,et al. Prostate cancer: incremental value of endorectal MR imaging findings for prediction of extracapsular extension. , 2004, Radiology.
[9] Chinyere N. Onyebuchi,et al. The role of preoperative endorectal magnetic resonance imaging in the decision regarding whether to preserve or resect neurovascular bundles during radical retropubic prostatectomy , 2004, Cancer.
[10] Chinyere N. Onyebuchi,et al. Advances in imaging in the postoperative patient with a rising prostate-specific antigen level. , 2003, Seminars in oncology.
[11] Ralph Weissleder,et al. Noninvasive detection of clinically occult lymph-node metastases in prostate cancer. , 2003, The New England journal of medicine.
[12] A. Partin,et al. Management of high-risk populations with locally advanced prostate cancer. , 2003, The oncologist.
[13] D. Bostwick,et al. Contemporary pathology of prostate cancer. , 2003, The Urologic clinics of North America.
[14] N. Aaronson,et al. Health related quality of life in men with prostate cancer. , 2003, The Journal of urology.
[15] M. Kattan,et al. Bladder neck involvement in pathological stage pT4 radical prostatectomy specimens is not an independent prognostic factor. , 2002, The Journal of urology.
[16] A. Renshaw,et al. Evolution of the presentation and pathologic and biochemical outcomes after radical prostatectomy for patients with clinically localized prostate cancer diagnosed during the PSA era. , 2002, Urology.
[17] A W Partin,et al. Contemporary update of prostate cancer staging nomograms (Partin Tables) for the new millennium. , 2002, Urology.
[18] L. Klotz,et al. The role of serial free/total prostate‐specific antigen ratios in a watchful observation protocol for men with localized prostate cancer , 2002, BJU international.
[19] Peter Carroll,et al. Rising PSA after a Radical Treatment , 2001, European Urology.
[20] J. Pow-Sang,et al. Observation in the management of localized prostate cancer. , 2001, Cancer control : journal of the Moffitt Cancer Center.
[21] U Pichlmeier,et al. A validated strategy for side specific prediction of organ confined prostate cancer: a tool to select for nerve sparing radical prostatectomy. , 2001, The Journal of urology.
[22] A W Partin,et al. Validation of Partin tables for predicting pathological stage of clinically localized prostate cancer. , 2000, The Journal of urology.
[23] J Kurhanewicz,et al. Prostate cancer: prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging. , 1999, Radiology.
[24] W. Catalona,et al. Contemporary results of anatomic radical prostatectomy , 1999, CA: a cancer journal for clinicians.
[25] S. Friis,et al. Mortality of patients with clinically localized prostate cancer treated with observation for 10 years or longer: a population based registry study. , 1999, The Journal of urology.
[26] O. Ogawa,et al. Preoperative Predictors for Organ‐Confined Disease in Japanese Patients with Stage T1c Prostate Cancer , 1998, International journal of urology : official journal of the Japanese Urological Association.
[27] S B Malkowicz,et al. Endorectal coil magnetic resonance imaging identifies locally advanced prostate cancer in select patients with clinically localized disease. , 1998, Urology.
[28] J. Kurhanewicz,et al. Improved water and lipid suppression for 3D PRESS CSI using rf band selective inversion with gradient dephasing (basing) , 1997, Magnetic resonance in medicine.
[29] A W Partin,et al. Combination of prostate-specific antigen, clinical stage, and Gleason score to predict pathological stage of localized prostate cancer. A multi-institutional update. , 1997, JAMA.
[30] A. D'Amico,et al. A multivariate analysis of clinical and pathological factors that predict for prostate specific antigen failure after radical prostatectomy for prostate cancer. , 1995, The Journal of urology.
[31] K. Gohji,et al. USEFULNESS OF DIGITAL RECTAL EXAMINATION, SERUM PROSTATE‐SPECIFIC ANTIGEN, TRANSRECTAL ULTRAS ONOGRAPHY AND SYSTEMATIC PROSTATE BIOPSY FOR THE DETECTION OF ORGAN‐CONFINED PROSTATE CANCER , 1995, International journal of urology : official journal of the Japanese Urological Association.
[32] C W Piccoli,et al. Staging of prostate cancer: results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques. , 1994, Radiology.
[33] W. Catalona,et al. Detection of organ-confined prostate cancer is increased through prostate-specific antigen-based screening. , 1993, JAMA.
[34] H. Hricak,et al. MR imaging of the seminal vesicles. , 1991, AJR. American journal of roentgenology.
[35] W. Whitmore,et al. Frozen section lymph node analysis in pelvic lymphadenectomy for prostate cancer. , 1988, The Journal of urology.
[36] K. Uğurbil,et al. NMR chemical shift imaging in three dimensions. , 1982, Proceedings of the National Academy of Sciences of the United States of America.
[37] A. Jemal,et al. Cancer Statistics, 2005 , 2005, CA: a cancer journal for clinicians.
[38] Pierre I Karakiewicz,et al. Comparison of accuracy between the Partin tables of 1997 and 2001 to predict final pathological stage in clinically localized prostate cancer. , 2004, The Journal of urology.
[39] Pierre I Karakiewicz,et al. Can predictive models for prostate cancer patients derived in the United States of America be utilized in European patients? A validation study of the Partin tables. , 2003, European urology.
[40] J Kurhanewicz,et al. Three-dimensional magnetic resonance spectroscopic imaging of brain and prostate cancer. , 2000, Neoplasia.
[41] T. Wilt,et al. Prostate Intervention Versus Observation Trial (PIVOT): a randomized trial comparing radical prostatectomy with palliative expectant management for treatment of clinically localized prostate cancer. PIVOT Planning Committee. , 1995, Journal of the National Cancer Institute. Monographs.
[42] R. Peschel,et al. Preoperative serum prostate-specific antigen and Gleason grade as predictors of pathologic stage in clinically organ confined prostate cancer: implications for the choice of primary treatment. , 1994, International journal of radiation oncology, biology, physics.